Aerie Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 3.12, indicating more challenging environment then in the second quarter 2022, but still, it is a far cry from any concerns. Average collection period, for Aerie Pharmaceuticals Inc 's accounts receivable remained unchanged at 117 days, in the Sep 30 2022 quarter.

If we take a look into Healthcare sector 578 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3471, from overall ranking in the second quarter 2022 at 3500.

What is Receivable Turnover Ratio?
What is Aerie Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AERI Receivables Turnover Ratio	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter
Y / Y Receivable Change	14.43 %	15.1 %	37.85 %	22.86 %	37.82 %
Y / Y Revenue Change	23.25 %	22.53 %	29.89 %	364.55 %	45.97 %
Receivable Turnover Ratio (TTM)	3.12	3.13	3.14	3.25	1.84
AERI's Total Ranking	# 3471	# 3500	# 3504	# 3877	# 3447
Accounts Receivable average collection period days	117	117	116	112	198
Seq. Receivable Change	8.52 %	7.02 %	-7.57 %	6.6 %	9.15 %
Seq. Revenue Change	8.46 %	11.65 %	-73.98 %	291.18 %	7.83 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 57
Healthcare Sector	# 579
Overall Market	# 3471

Receivable Turnover Ratio Statistics
High	Average	Low
6.82	2.86	1.76
(Mar 31 2019)		(Dec 31 2020)

AERI Company Profile • Back to AERI Efficiency Comparisons • Compare AERI Receivables Turnover Ratio to its Competitors

Financial Statements
Aerie Pharmaceuticals Inc 's Accounts Receivable	$ 74 Millions	Visit AERI's Balance sheet
Aerie Pharmaceuticals Inc 's Sales TTM	$ 214 Millions	Visit AERI's Income Statement
Sources of AERI's Revenues		Visit AERI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AERI's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AERI's Growth Rates	AERI's Roa	AERI's Inventory Turnover Ratio	AERI's Dividend Comparisons
AERI's Profitability Ratios	AERI's Roi	AERI's Asset Turnover Ratio	AERI's Dividend Growth
AERI's Valuation Ratios	AERI's Roe	AERI's Financial Strength Ratios	AERI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2022	Receivable at quarter ending Sep 30 2022
Becton Dickinson And Company	7.96	$ 18,332.000 Millions	$ 2,302.250 Millions
Scientific Industries Inc	7.94	$ 11.216 Millions	$ 1.413 Millions
Alpha Teknova Inc	7.92	$ 43.629 Millions	$ 5.509 Millions
Finch Therapeutics Group Inc	7.90	$ 1.659 Millions	$ 0.210 Millions
Mymetics Corporation	7.84	$ 1.081 Millions	$ 0.138 Millions
Durect Corp	7.84	$ 23.265 Millions	$ 2.968 Millions
Enovis Corp	7.83	$ 3,358.906 Millions	$ 429.218 Millions
Traws Pharma inc	7.82	$ 0.217 Millions	$ 0.028 Millions
Vapotherm Inc	7.82	$ 70.382 Millions	$ 9.002 Millions
Tela Bio Inc	7.79	$ 38.075 Millions	$ 4.885 Millions
Q Biomed inc	7.78	$ 0.377 Millions	$ 0.048 Millions
Encision Inc	7.77	$ 7.406 Millions	$ 0.953 Millions
Lemaitre Vascular Inc	7.75	$ 160.200 Millions	$ 20.663 Millions
Chembio Diagnostics Inc	7.75	$ 59.752 Millions	$ 7.707 Millions
Maravai Lifesciences Holdings Inc	7.68	$ 906.732 Millions	$ 118.073 Millions
Butterfly Network Inc	7.66	$ 72.766 Millions	$ 9.502 Millions
Quest Diagnostics Inc	7.65	$ 10,294.000 Millions	$ 1,345.500 Millions
Atrion Corporation	7.64	$ 180.944 Millions	$ 23.690 Millions
Nuwellis Inc	7.63	$ 7.846 Millions	$ 1.029 Millions
Therapeutic Solutions International Inc	7.62	$ 0.242 Millions	$ 0.032 Millions
Cormedix Inc	7.62	$ 0.092 Millions	$ 0.012 Millions
Evolus Inc	7.61	$ 139.627 Millions	$ 18.351 Millions
Aveanna Healthcare Holdings Inc	7.57	$ 1,750.568 Millions	$ 231.271 Millions
Cutera Inc	7.56	$ 250.675 Millions	$ 33.161 Millions
Amedisys Inc	7.55	$ 2,220.452 Millions	$ 294.106 Millions
Inari Medical Inc	7.54	$ 358.918 Millions	$ 47.633 Millions
AnTix Holdings, Inc.	7.53	$ 1.365 Millions	$ 0.181 Millions
Resmed Inc	7.52	$ 4,359.678 Millions	$ 579.826 Millions
Tandem Diabetes Care Inc	7.51	$ 790.712 Millions	$ 105.357 Millions
Cytosorbents Corporation	7.50	$ 36.081 Millions	$ 4.808 Millions

Date modified: 2026-08-29T17:18:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.